Recombinant Human CDC25B (aa 377-566) Protein, CF

Catalog # Availability Size / Price Qty
1649-CD-050
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
FAQs
Reviews

Recombinant Human CDC25B (aa 377-566) Protein, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to cleave a substrate, p-Nitrophenyl phosphate (pNPP). The specific activity is >70 pmol/min/μg, as measured under the described conditions.
Source
E. coli-derived human CDC25B protein
Glu377-Gln566, with an N-terminal Met and 6-His tag
Accession #
N-terminal Sequence
Analysis
Met
Structure / Form
Based on mass spectrometric analysis, a carboxyl-terminal truncated peptide with a molecular mass of approximately 22.1 kDa may also be present in the recombinant protein preparation.
Predicted Molecular Mass
23 kDa
SDS-PAGE
23-25 kDa, reducing conditions

Product Datasheets

You must select a language.

x

1649-CD

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

1649-CD

Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, EDTA, DTT and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Assay Procedure

Materials
  •     Assay Buffer:  50 mM HEPES, 10 mM DTT, pH 7.5
  •     Recombinant Human CDC25B aa 377‑566 (rhCDC-25B) (Catalog # 1649-CD)
  •     Substrate: p-Nitrophenyl phosphate (pNPP), 10 mM stock in deionized water
  •     Sodium Hydroxide (NaOH), 0.2 M stock in deionized water
  •     Clear 96-well Plate (Catalog # DY990)  
  •     Plate Reader with absorbance read capability
  1. Dilute rhCDC-25B to 20 µg/mL in Assay Buffer.
  2. Dilute Substrate to 6 mM in Assay Buffer.
  3. Prepare reaction mixtures by combining equal volumes of dilute rhCDC-25B and dilute Substrate in microtubes. Include an Enzyme Control by combining dilute rhCDC-25B with twice the volume of 0.2 M NaOH, mix briefly; then add a volume of dilute Substrate equal to the volume of dilute rhCDC-25B. The Enzyme Control will have 2x the volume of the reaction mixture.
  4. Incubate Reactions and Enzyme Control at 37 °C for 4 hours.
  5. Load 100 µL of Reactions into a plate and stop the reactions by adding 100 µL 0.2 M NaOH.
  6. Load 200 µL of Enzyme Controls into plate.
  7. Read plate at 410 nm (absorbance) in endpoint mode.
  8. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Abs* (OD) x Conversion Factor** (pmol/OD)
Incubation time (min) x amount of enzyme (µg)

*Adjusted for Enzyme Controls
**Derived using calibration standard p-Nitrophenol
Per Well:
  • rhCDC-25B: 1 µg
  • pNPP: 1.5 mM
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CDC25B

Cell Division Cycle 25B (Cdc25B) phosphatase removes inorganic phosphate groups covalently attached to tyrosine, serine and threonine residues in proteins (1). Breast cancer patients bearing tumors containing high levels of Cdc25B have been found to have a greater incidence of aggressive, high‑grade tumors than those with low Cdc25B levels (2). In cells, the levels of Cdc25B activity are highest during the G2/M transition of the cell cycle, where it is suspected to be involved in “checkpoint” control of cell cycle progression (3). Overexpression of Cdc25B reduces the G2/M cell cycle block caused by ionizing radiation (4). Although activated by phosphorylation, Ser323 phosphorylation causes the enzyme to bind the protein 14-3-3, preventing substrate access to the catalytic site (5). One of the major substrates of Cdc25B is Cdc2, a kinase that is activated by dephosphorylation (6). The recombinant protein is truncated to remove the N-terminal regulatory domains and is fully active.

References
  1. Draetta, G. and J. Eckstein (1997) Biochim. Biophys. Acta 1332:M53.
  2. Galaktionov, K. et al. (1995) Science 269:1575.
  3. Lammer, C. et al. (1998) J. Cell Sci. 111:2445.
  4. Miyata, H. et al. (2001) Cancer Res. 61:3188.
  5. Forrest, A. and B. Gabrielli (2001) Oncogene 20:4393.
  6. Gautier, J. et al. (1991) Cell 67:197.
Long Name
Cell Division Cycle 25B
Entrez Gene IDs
994 (Human)
Alternate Names
CDC25B; CDC25HU2; cell division cycle 25 homolog B (S. cerevisiae); cell division cycle 25 homolog B (S. pombe); cell division cycle 25B; Dual specificity phosphatase Cdc25B; EC 3.1.3.48; M-phase inducer phosphatase 2

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human CDC25B (aa 377-566) Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human CDC25B (aa 377-566) Protein, CF and earn rewards!

Have you used Recombinant Human CDC25B (aa 377-566) Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review